lncRNA-mediated ceRNA network in bladder cancer.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Bladder cancer presents significant morbidity and mortality.
• Current immunotherapies like T-cell therapy and immune checkpoint blockade show limitations due to off-target effects and single-target specificity.
• Novel therapeutic targets are crucial for effective control of bladder cancer growth and metastasis.

Purpose of the Study:

• To review the roles and mechanisms of long noncoding RNA (lncRNA)-mediated competing endogenous RNA (ceRNA) networks in bladder cancer progression.
• To discuss the potential of targeting lncRNA-mediated ceRNA networks for overcoming cancer treatment resistance.
• To explore the association between lncRNA-mediated ceRNA networks, clinicopathological features, and patient outcomes in bladder cancer.

Main Methods:

• Literature review focusing on lncRNAs and ceRNA networks in bladder cancer.
• Analysis of existing evidence on the regulatory functions of lncRNAs in cancer cell proliferation, migration, invasion, apoptosis, and epithelial-mesenchymal transition (EMT).
• Discussion of therapeutic strategies targeting lncRNA-mediated ceRNA networks.

Main Results:

• Dysregulated lncRNAs are involved in key processes of bladder cancer progression, including proliferation, migration, invasion, apoptosis, and EMT.
• lncRNA-mediated ceRNA networks play a significant role in regulating gene expression within bladder cancer cells.
• Targeting these networks shows potential for overcoming resistance to existing cancer treatments.

Conclusions:

• lncRNAs are critical regulators in bladder cancer, influencing various aspects of tumor progression.
• lncRNA-mediated ceRNA networks represent a promising avenue for developing novel therapeutic strategies against bladder cancer.
• Further research into these networks could lead to improved treatment approaches and better patient outcomes.